Hyperion DeFi is the first U.S. publicly listed company building on Hyperliquid, one of the highest revenue-generating blockchains in the world. We hold a long-term strategic treasury of HYPE and deploy it across diversified strategies — generating revenues that no passive holder can replicate.
Hyperion holds one of the largest corporate treasuries of HYPE, the native token of the Hyperliquid blockchain, accumulated under a long-term mandate to maximize yield on HYPE.
The 'Kinetiq x Hyperion' validator operates on institutional-grade infrastructure, earning Hyperliquid's native staking yield — a durable baseline that anchors every operating strategy.
Hyperion pioneered the operating-company model for digital asset treasuries: deploying HYPE across market infrastructure, staking-linked services, institutional credit, and systematic volatility strategies.
HYPD is Nasdaq-listed and SEC-reporting, with independent audit and board oversight — providing access to the Hyperliquid economy through public equity, under the controls that institutional mandates require.
Kinetiq
The leading liquid staking platform built on Hyperliquid, with nearly $1 billion in HYPE staked via Kinetiq.
LEARN MORE
Chief Executive Officer
Hyunsu has served as the Company's Chief Executive Officer since January 2026, and as the Company's Chief Investment Officer and a director since June 2025.
Chief Financial Officer
David brings with him extensive expertise in scaling capital markets strategies and financial services businesses.
General Counsel and Secretary
Robert brings nearly three decades of experience leading legal, compliance, and business development functions for multi-national public and private companies.
Third-party data is provided for informational purposes only and does not constitute an endorsement by Hyperion DeFi.
Access financial reports, SEC filings, governance documents, and real-time asset data through the Hyperion DeFi investor portal.
Visit Investor PortalInvestor, partner, or builder — we'd like to hear from you. Shareholder and analyst inquiries are best directed to Investor Relations; for partnerships and institutional opportunities, use the form and our team will respond promptly.
